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Abbreviations: 
CIN: (R)-cinacalcet  
CryoSEM: Cryoscopic Scanning Electronic Microscopy  
DLS: Dynamic Light Scattering  
EE: Encapsulation efficiency  
Es: Singlet energy 
HPLC: High performance liquid chromatography 
kFq: Fluorescence quenching rate constant for oxygen 
kTq: Triplet quenching rate constant for oxygen 
Lip: Liposome 
LFP: Laser flash photolysis  
LUV: Large unilamellar liposomes  
NPX: (S)-naproxen  
PBS: Phosphate buffered saline solution  
PC: 1,2-dioleoyl-sn-glycero-3-phosphocholine  
PTI: Photon Technology International  
TEM: Transmission Electronic Microscopy  
TLE: Thin layer evaporation  
τs: Singlet lifetime 
τT: Triplet lifetime 
UV-Vis: Ultraviolet–visible  
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Abstract 
The photophysical and photochemical behavior of (R)-cinacalcet (CIN) and (S)-naproxen (NPX) 
entrapped within liposomes has been studied. For this purpose, liposome encapsulated drugs have been 
prepared through thin layer evaporation and characterized by transmission electron microscopy, 
cryoscopy scanning electron microscopy and dynamic light scattering. Steady state and time-resolved 
fluorescence experiments showed similar spectra, emission quantum yields, singlet energies and 
lifetimes for the selected drugs, outside and inside liposomes. By contrast, laser flash photolysis 
experiments revealed an important enhancement of the triplet lifetimes for entrapped drugs inside 
liposomes, indicating the spatial confinement existing in the microenvironment prevailing in these 
biomimetic entities. Thus, this photophysical property shows potential as a non-invasive, direct and 
valuable tool to monitor encapsulation of photoactive drugs and to probe the intraliposome environment. 
In addition, it provides a new quantitative indicator of the capability of liposomes to act as drug carriers. 
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Introduction 
Liposomes are the smallest artificial vesicles of spherical shape that can be produced from natural 
phospholipids and cholesterol. They are very versatile tools in biology, biochemistry and 
medicine[1,2,3,4,5] and have attracted attention as potential vehicles for drug delivery to selected cells 
or tissues in vivo and as carriers of drugs or other bioactive compounds including proteins, hormones 
and diagnostic agents.[6,7] Although the interest has been mainly focused on drug delivery, a variety of 
other applications have been found in cosmetics, cleansing and food technology.[6,8]  
Liposomes are simple biomimetic models for cell membranes and provide appropriate 
microenvironment for the study of photoinduced electron transfer[9] and lipid peroxidation.[10,11] 
Adoption of this matrix seems very promising in photodynamic therapy, based on the generation of 
reactive oxygen species that destroy the tissues or target cells by the use of photosensitizing compounds, 
which absorb photons and are excited to a triplet state, capable of generating superoxide anion or 
promoting molecular oxygen to its highly reactive singlet state. This mechanism seems responsible for 
cell death in tumor tissues or for stimulation of immune responses that cause cell death. Despite the 
progress made in the study of clinically available photosensitizing agents, there are still several 
drawbacks limiting their use. For example, their hydrophobic nature limits their efficiency and delivery 
in the body. To circumvent these problems, alternative formulations are required to enhance solubility 
and to achieve selective delivery to tumor sites. In this context, liposomes have the ability to encapsulate 
hydrophobic molecules. Inclusion of photosensitizers within this type of matrix has revealed a good 
correlation between the physicochemical features of formulations and their photosensitizing 
efficiency.[12] Moreover, interaction of light with photosensitive liposomes may cause membrane 
reorganization and offers an appropriate tool for selective drug release in the target site, with a 
significant impact on the therapeutic index of drugs. Additional applications of this effect can be found 
in imaging or sensing.[13] The study of molecular mechanisms that result in photo-destabilization of 
liposome membranes is essential in developing light-activable liposomes for photodynamic therapy with 
higher opportunities of success in the clinical practice.[14] 
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Recently, naphthalene-like triplet excited states have been used as reporters for the interaction of 
drugs with transport proteins[15,16,17] and for the incorporation of photoactive compounds within 
cholic acid aggregates[18] and mixed micelles.[19] In the present work, two naphthalene-derived drugs, 
namely (R)-Cinacalcet (CIN) and (S)-Naproxen (NPX) have been entrapped within liposomes, and 
photophysical studies have been performed in order to establish how this microenvironment influences 
the excited state dynamics of both drugs. The chemical structures of CIN and NPX are reported in 
Chart1. The former (CIN) is a recently marketed calcimimetic drug, mimicking the action of calcium on 
tissues, by allosteric activation of the calcium-sensing receptor.[20,21] This agent is used for treatment 
of persistent hyperparathyroidism in renal transplanted patients, with chronic kidney disease and renal 
failure in dialysis.[22,23,24] It is also used for the treatment of hypercalcemia in patients with 
parathyroid carcinoma, in order to decrease the calcium level in blood.[25,26,27] As regards NPX it is 
widely used as a highly effective nonsteroidal anti-inflammatory drug. Although NPX is rather safe and 
tolerable, serious gastrointestinal side effects, and in some cases skin photosensitivity, may appear after 
oral administration.[28,29,30,31] Besides, it exhibits red blood cells photohaemolytic activity and 
causes photocleavage of DNA.[28,29,32]  
At the present stage, our goal is to assess the entrapment of both naphthalene-derived drugs within 
biomimetic liposomes by means of non-invasive and straightforward spectroscopic tools, specifically 
fluorescence and laser flash photolysis (LFP). Selection of CIN and NPX as probes seems appropriate, 
since they present a two-channel responsive chromophore and appear in principle suitable systems to 
evaluate their encapsulation inside liposomes by photophysical techniques.  
 
Materials and Methods 
Materials. NPX and 1,2-dioleoyl-sn-glycero-3-phosphocholine (PC), with purity higher than 99 %, 
were purchased from Sigma–Aldrich (Steinheim, Germany). The latter was stored as purchased at -
20°C. CIN was extracted from commercial Mimpara 60 mg (Amgen, Spain). The content of six pills 
was powdered in a mortar, suspended in NH4OH 1 M (50 mL) and extracted with CH2Cl2 (4 x 50 mL). 
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The combined organic layers were washed with brine (3 x 150 mL) and water (3 x 150 mL), dried over 
MgSO4, and evaporated under reduced pressure. The residue was purified by column chromatography 
through silica gel 60 (dichloromethane:methanol:ammonium hydroxide 98:2:0.1 v/v/v) to give CIN as a 
colorless oil. The purity of isolated CIN was higher than 98 % as indicated by 1H and 13C NMR 
spectroscopy. Chloroform and methanol were of HPLC grade from Scharlab (Sentmenat, Spain) and 
were used without further purification. Phosphate buffered saline solution (PBS) (pH = 7.4, 0.01 M) was 
prepared by dissolving Sigma tablets in the appropriate amount of purified water (Milli-Q system, 
Millipore).  
Preparation of liposomes. Liposomes including CIN and NPX were prepared by thin layer 
evaporation (TLE) method according to standard conditions.[33,34] Liposomes were obtained 
dissolving 12.1 mg of PC in 10 mL of chloroform containing the drug (ca. 2 x 10-3 M) in a 50 mL round-
bottomed flask. Drug-free liposomes were prepared as blank. The solutions were evaporated at 58 °C by 
using a vacuum rotary evaporator for 10 min., to remove the organic solvents. Then, the residual solvent 
was completely eliminated by drying under vacuum for 2 hours. The obtained lipid film was hydrated 
with 2 mL of PBS, leading to a liposomal formulation. Large unilamellar liposomes (LUV) were 
produced starting from multilamellar ones by sonication in an ultrasonic bath for 30 min at 50 °C. In this 
way, more homogeneous size vesicles were obtained; they were kept under controlled temperature (4 
°C) until their use within 3 days. Immediately before use, 0.5 mL of liposome emulsion were added to 
the same amount of PBS and purified by centrifugation at 14000 x g during 10 min for 3 times at room 
temperature in a HERAUS Pico 21 centrifuge (Thermo electron corporation, Germany).  
Size analysis. Liposomes were characterized by Transmission Electronic Microscopy (TEM), 
Cryoscopic Scanning Electronic Microscopy (CryoSEM) and Dynamic Light Scattering (DLS). TEM 
observation of liposomes was carried out by a JEOL2010-FEG TEM/STEM microscope, equipped with 
a field emission electron source and an objective lens with Cs value of 0.5 mm. The images were 
digitally recorded on a 1024 x 1024 CCd camera. Image analysis was performed using routines 
implemented in the software plugins of Digital Micrograph. For TEM measurements, 5 µL of purified 
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liposomes were put on a holey-carbon coated 3-mm Cu-grid and dried at room temperature under a 
cabinet equipped with an aspiration system. After complete evaporation of the solvent, the sample was 
ready for direct observation. SEM images were obtained using a JEOL JSM-6300 microscope operating 
at 20 kV. For CryoSEM analysis, samples were frozen, and thin frozen sections were imaged without 
staining. For both microscopic analysis liposomes were rehydrated with Millipore water instead of PBS, 
in order to avoid the optical interference of saline crystals in the medium. DLS measurements were 
conducted using a Zetasizer Nano ZS (Malvern Instruments Ltd., Worcestershire, United Kingdom). The 
liposomes were diluted with deionized water and the experiments were performed at 25 oC and 173 o 
scattering angle. The mean hydrodynamic diameter was determined by cumulant analysis. 
Drug entrapment efficiency. The encapsulation efficiency (EE) of CIN and NPX was determined 
using equation 1;[35] it is expressed as the percentage of the drug trapped in purified liposomes referred 
to the non purified solutions. 
Encapsulation efficiency (%) = 100×−
Ct
CoCt
      (1) 
where Co  is the concentration in the supernatant diluted with PBS and Ct  refers to the liposome 
emulsion diluted with warm ethanol (70°C), for disruption of the liposomes and release of the included 
drug to the solvent. The amount of entrapped drug was determined from the absorbance of the samples 
by UV-Vis spectrophotometry at the maximum (230 nm). Encapsulation efficiency was verified at each 
preparation of new batch of liposomes. 
Spectroscopic measurements. UV spectra were recorded on a Cary 300 (Varian) spectrophotometer.  
Steady-state fluorescence experiments were carried out using a Photon Technology International (PTI, 
Germany) LPS-220B spectrofluorometer, equipped with a monochromator in the wavelength range of 
200-700 nm. The time-resolved fluorescence determinations were performed with a Time Master 
fluorescence lifetime spectrometer TM 2/2003 from PTI, using a hydrogen/nitrogen flash lamp as the 
excitation source. The kinetic traces were fitted by exponential functions, with using a reconvolution 
procedure to separate from lamp pulse profile. For fluorescence measurements, concentrations were 
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fixed by adjusting the absorbance for CIN and NPX solutions at the arbitrary value of 0.1 at the 
excitation wavelength of 290 nm and 330 nm, respectively. Fluorescent quantum yield measurements 
were obtained with nitrogen-bubbled PBS solutions; the absorbance was adjusted at the excitation 
wavelength using NPX (φf = 0.47 in acetonitrile)[28] and 1-methylnaphthalene (φf = 0.19 in 
acetonitrile)[36] as standards. All experiments were conducted at room temperature using 10 x 10 mm2 
quartz cells with 4 mL capacity and were run in triplicate. 
Laser flash photolysis. Laser flash photolysis (LFP) experiments were performed by using a Q-
switched Nd:YAG laser (Quantel Brilliant, 266 nm, 14 mJ pulse-1, 5 ns fwhm) coupled to a mLFP-111 
Luzchem miniaturized equipment. In general, solutions were nitrogen-purged for 10 min before 
acquisition, and the triplet decays were registered at 420 nm. Samples were prepared in PBS, and the 
absorbance was kept at ca. 0.3. Solutions of CIN and NPX in PBS, treated in the same way as 
liposomes, were used as reference. All LFP analyses were performed at room temperature using 10 x 10 
mm
2
 quartz cells with 4 mL capacity and were run in triplicate. 
 
Results and Discussion 
Photophysical studies were performed on CIN and NPX entrapped within liposomes, in order to 
establish how this microenvironment influences the excited state dynamics of the drugs.  
Entrapment of drugs within liposomes. Large unilamellar liposomes (LUV) have been reported since 
1965 as membrane biomimetics.[37,38] In this work, optimization of the classical TLE method was 
carried out in an attempt to increase the encapsulation efficiency (EE) and to obtain liposomes with 
homogeneous size. Thus, the EE were ca. 40 % in all cases. Moreover, this parameter appeared to be 
very sensitive to the storage of liposomes. In fact, whereas the preparations were stable at 4° C for at 
least 3 days, maintenance at room temperature caused a progressive decrease of EE, which dropped to 
15 % after 2 days, with an important transfer of free drug from liposomes to the PBS solution.  
The obtained solutions were characterized using DLS, TEM and CryoSEM microscopy (Figure 1). 
The diameter of prepared liposomes was determined using DLS measurements. This size was found in 
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the range of 80-260 nm (with a maximum at 130 nm and PDI ca. 0.3) corresponding to LUV, which 
makes them appropriate as biomimetic models. Both microscopy techniques are also suitable to 
investigate the size and external features of the liposomes. In particular, TEM analysis is widely used in 
this field[39] because it can offer an unrefined image of the liposomal profile and permits size 
measurements. On the other hand, CryoSEM analysis shows liposome morphology in the hydrated state: 
in general, the expected spheroidal shape was observed. Uniform and compact bilayers, a typical mark 
of unilamellar liposomes, were clearly identified; smaller liposomes were rarely observed (Figure 1A). 
In some cases, small inclusions on the surface were found, probably lipids from disrupted liposomes 
during analysis, in contact with the same surface.  
 
Figure 1. 
Photophysics of drugs within liposomes. The emission spectra of CIN and NPX in homogeneous 
medium and incorporated within liposomes were recorded at room temperature, using 290 nm and 330 
nm as the excitation wavelengths, respectively (see Figure 2). This selection was done in order to 
promote the chromophores to their lowest-lying singlet excited states, which usually results in enhanced 
selectivity and emission efficiency. This way, the bulk concentrations needed to obtain absorbance of ca. 
0.1 are in the order of 10-5 M. Solutions of CIN and NPX outside and inside liposomes showed the same 
spectra, displaying their corresponding maxima at 320 and 355 nm. The lack of a significant 
bathochromic or hypsochromic shift associated with encapsulation indicates that emission from these 
photoactive units is not particularly sensitive to the hydrophobic medium provided by the liposomes. 
The shape and position of the main bands of excitation spectra were essentially coincident with those of 
the absorption spectra. This confirms that emission takes place from the locally excited singlet and does 
not involve impurities, ground-state complexes or aggregates. From the intersection between normalized 
excitation and emission traces, singlet energies (Es) were obtained for all systems (Table 1). The values 
indicate little perturbation if any of the relevant molecular orbital levels. Accordingly, the fluorescence 
quantum yields inside liposomes for CIN (φf = 0.11) and NPX (φf = 0.40) were also similar to the values 
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obtained for the free drugs. In order to detect a possible dynamic quenching, time resolved fluorescence 
studies were carried out. In general, this type of quenching is detected through a faster decay and reveals 
a higher reactivity. This was not the case under the experimental conditions, as similar lifetimes were 
determined for the singlet excited state outside and inside liposomes.  
Table 1.  
The rate constant of singlet excited state quenching by oxygen in PBS was also determined using 
time-resolved fluorescence spectroscopy, recording decays under N2, air, and O2 atmosphere. The 
lifetimes of CIN and NPX within liposomes were slightly more sensitive to the presence of oxygen than 
those of the free drugs in solution. This was not unexpected, since both the real oxygen concentrations 
and the diffusion rate inside liposome should differ from the values found in bulk PBS. From these data, 
the apparent quenching rate constant by oxygen (assuming similar effective oxygen concentration) was 
determined by means of the Stern-Volmer relationships and found to be 1.4 x1010 M-1s-1 for free CIN 
and 1.5 x1010 M-1s-1 for liposome-encapsulated CIN, 8.8 x109 M-1s-1 for free NPX, 9.6 x109 M-1s-1 for 
liposome-encapsulated NPX. 
Figure 2. 
 
In addition to fluorescence measurements, LFP experiments were carried out in order to investigate 
the influence of liposome encapsulation drugs on the lifetime of the excited states, in the nanosecond-
microsecond timescale, using a Q-switched Nd:YAG laser for excitation at 266 nm, where the 
absorbance of the samples was ca. 0.3 (in the order of 10-4 M). This technique allows detecting longer-
lived transients, which may move and relocate during their lifetimes, or even establish a dynamic 
equilibrium between the populations of different compartments. Moreover, the wider dynamic range is 
more convenient for safe detection of slow processes and for assessment of possible protection of the 
species of interest from reaction with a variety of reagents, including oxygen or adventitious quenchers. 
The transient absorption spectra of CIN and NPX in solution exhibited the typical naphthalene-like 
triplet−triplet absorption band[28] in the 420-450 nm region that remained unchanged upon 
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encapsulation inside liposome (Figure 3). However, it is worth mentioning that the spectra of Figure 3 
show the absence of naphthalene-like radical cations, which appear in PBS solution in the long-
wavelength edge of the selected window, especially in the case of NPX. This is consistent with the 
hydrophobic nature of the intraliposome region, which prevents photoionization. 
Interestingly, enhancements of the triplet lifetimes (beyond 40 µs) were observed for encapsulated 
drugs, revealing the sensitivity of this excited state to the experienced microenvironment (see Figure 3 
and Table 1). In this context, the liposomes can be considered as microheterogeneous systems, an 
expression commonly used for homogeneous media at the macroscopic level (looking like clear and 
transparent preparations), where distinct microscopic compartments are defined with different physico-
chemical properties (hydrophobicity, polarity, viscosity, refraction index, etc.), which results in a 
significant degree of anisotropy. Further examples of microheterogeneous systems are cyclodextrins,[40] 
micelles,[19,41] transport proteins,[42] nanoparticles,[43] bile salt aggregates,[18] etc. Again, the 
apparent triplet quenching rate constants were determined from the triplet lifetimes under N2, air and O2, 
in the different media. The obtained values were 1.8 x109 M-1s-1 for free CIN, 1.2 x109 M-1s-1 for 
liposome-encapsulated CIN, 2.0 x109 M-1s-1 for free NPX and 9.9 x108 M-1s-1 for liposome-encapsulated 
NPX. Thus, the medium-dependent decay of the triplet excited states of CIN and NPX, as revealed by 
the lengthening of the lifetimes, is the most sensitive photophysical parameter to the nature of the 
microenvironment provided by the interior of liposomes. As a consequence, this property can in 
principle be used to monitor encapsulation of photoactive drugs and to probe the interior of these 
biomimetic systems. 
Figure 3. 
 
Conclusions 
The present work has revealed an efficient inclusion of the drugs in the microenvironment provided by 
liposomes. The most remarkable photophysical property is the increase in the triplet lifetimes of CIN 
and NPX observed inside liposomes. This agrees well with the spatial confinement existing in the 
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interior of such biomimetic systems, where the degrees of freedom and hence the possibilities of 
nonradiative decay are restricted. Hence, transient absorption spectroscopy is a non-invasive, direct and 
valuable tool to assess the encapsulation of photoactive drugs inside liposomes and its influence on the 
excited state dynamics, thus providing a new quantitative indicator of the capability of liposomes to act 
as drug carriers. 
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Figure 1 
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Figure 2 
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Figure 3 
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Table 1 
Sample τs (ns)a Es (kcal /mol)b kFq (M-1sec-1)c τT (µs)d kTq (M-1sec-1)e 
CIN 31 92 1.4 x 1010 29 1.8 x 109 
CIN Lip 30 92 1.5 x 1010 46 1.2 x 109 
NPX 9.9 85 8.8 x 109 25 2.0 x 109 
NPX 
Lip 8.8 85 9.6 x 10
9
 45 9.9 x 108 
a
 Singlet lifetime. b Singlet energy. c Fluorescence quenching rate constant for oxygen. 
 d
 Triplet lifetime. e Triplet quenching rate constant for oxygen. 
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Captions 
 
Chart 1. Chemical structures of CIN and NPX  
 
Figure 1. A) DLS size distribution curves for liposomes in PBS. Insets: CryoSEM image (left) and 
TEM image (right). B) Cartoon representation of the drug inside liposome. 
 
Figure 2. Normalized emission () and excitation () spectra of A) CIN (λexc = 290 nm, A290 = 0.1) 
and B) NPX (λexc = 330 nm, A330 = 0.1) in PBS solution (black) and inside liposome (grey). 
 
Figure 3. Transient absorption spectra (λexc = 266 nm) under N2 of A) CIN and B) NPX inside 
liposomes. Insets: Normalized decay traces for the drugs in PBS (black) and within liposomes (grey) 
monitored at 420 nm. 
 
Table 1. Photophysical parameters of CIN and NPX outside and inside liposomes. 
 
 
